CVE-2023-0090 | BDVDB-2026-197000 Detail

proofpointenterprise_protection

Description#

The webservices in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows for an anonymous user to execute remote code through 'eval injection'. Exploitation requires network access to the webservices API, but such access is a non-standard configuration. This affects all versions 8.20.0 and below.

Impact#

Per CVSS v3.1: confidentiality impact high, integrity impact high, availability impact high. Attack vector: network.

Weaknesses#

CWE-95 Improper Neutralization of Directives in Dynamically Evaluated Code ('Eval Injection')

References#

https://www.proofpoint.com/security/security-advisories/pfpt-sa-2023-0001

Exploit#

No public exploit known

History#

Version 12023-03-08Record published in the CVE List.
Version 22025-02-28Most recent update recorded in the CVE List.

Published

Published: 2023-03-08
Last modified: 2025-02-28

Vendor information

Vendor: proofpoint
Product: enterprise_protection

All proofpoint vulnerabilities

Score

9.8 Critical

EPSS

less than 1%, Very Low

Estimated chance of exploitation in the next 30 days. EPSS percentile: 55.1.

KEV

Not listed in the CISA Known Exploited Vulnerabilities catalog.

Impact

Not classified

Action

No specific action is recorded in the source data. Check the references for vendor guidance.

Affected Systems

Vulnerable
<= 8.20.0
Fixed
Not stated
Vulnerable
Not stated
Fixed
8.20.0 patch 4570
Vulnerable
Not stated
Fixed
8.18.6 patch 4568
Vulnerable
Not stated
Fixed
8.18.4 patch 4567
Vulnerable
Not stated
Fixed
8.13.22 patch 4566

Scoring System

CVSS v4.0

Not available

CVSS v3.1

9.8 Critical

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Metric breakdown
Attack Vector	Network
Attack Complexity	Low
Privileges Required	None
User Interaction	None
Scope	Unchanged
Confidentiality	High
Integrity	High
Availability	High

CVSS v3.0

Not available

CVSS v2

Not available

Source: CVE List v5 (record); CISA KEV (kev, action); FIRST EPSS (epss).